JESSICA SIAS: Open Payments
NPI 1679942189 · PHILIPPI, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,268 in 112 payments from 15 companies in 2025. Trend: 2023 $1,209 · 2024 $1,550 · 2025 $2,268
Food & beverage: $2,268
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $968 |
| AstraZeneca Pharmaceuticals LP | 7 | $274 |
| GlaxoSmithKline, LLC. | 12 | $236 |
| Merck Sharp & Dohme LLC | 5 | $148 |
| Novo Nordisk Inc | 7 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $89 |
| Verona Pharma, Inc. | 3 | $75 |
| Amgen Inc. | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $63 |
| SHIELD THERAPEUTICS INC | 1 | $48 |
Products named: VRAYLAR, UBRELVY, QULIPTA, AIRSUPRA, AREXVY, CAPVAXIVE, CAPLYTA, Ohtuvayre.
Industry payments across WV — which companies pay providers there.
